These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11139068)

  • 1. Tc-99m tetrofosmin uptake in male breast cancer.
    Marwah A; Kumar R; Sasan B; Sharma S; Bandopadhyaya GP; Malhotra A
    Clin Nucl Med; 2001 Jan; 26(1):77-8. PubMed ID: 11139068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
    Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
    Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scintimammography using Tc-99m tetrofosmin.
    Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
    Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
    Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
    Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
    Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F
    Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
    Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
    Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intense uptake of technetium-99m tetrofosmin by lactating breasts.
    Yamamoto W; Shuke N; Usui K; Aburano T; Takehara N; Kikuchi K
    Clin Nucl Med; 2001 Jan; 26(1):76-7. PubMed ID: 11139067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of 99Tcm-tetrofosmin scintimammography in palpable breast tumours.
    Batista JF; Solano ME; Oliva JP; Rodriguez JL; Gómez J; Stüsser RJ; Sánchez E
    Nucl Med Commun; 1997 Apr; 18(4):338-40. PubMed ID: 9170618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
    Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
    Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
    Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
    Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Tc-99m tetrofosmin imaging in the examination of patients with breast lesions.
    Schillaci O; Danieli R; Scopinaro F
    Radiology; 1999 Jan; 210(1):284-6. PubMed ID: 9885623
    [No Abstract]   [Full Text] [Related]  

  • 13. Tc-99m tetrofosmin uptake in a male patient with gynecomastia.
    Unzek S; Galla JM; Cerqueira MD; Jaber WA
    J Nucl Cardiol; 2007; 14(6):902-3. PubMed ID: 18022119
    [No Abstract]   [Full Text] [Related]  

  • 14. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
    Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
    Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer detection with Tc-99m tetrofosmin.
    Rambaldi PF; Mansi L; Procaccini E; Di Gregorio F; Del Vecchio E
    Clin Nucl Med; 1995 Aug; 20(8):703-5. PubMed ID: 7586873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of technetium-99m tetrofosmin mammoscintigraphy as compared to mammography for detecting and differentiating palpable breast masses of young Taiwanese women.
    Hoi YJ; Hsieh JF; Tsai SC; Sun SS; Kao CH
    Anticancer Res; 2000; 20(3B):2061-4. PubMed ID: 10928152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintigraphic evolution of a breast cancer with Tc-99m MIBI scintimammography.
    Mateos JJ; Vidal S; Muñoz M; Fuster D; Martin F; Ortega M; Pons F
    Clin Nucl Med; 2000 Sep; 25(9):701-3. PubMed ID: 10983758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
    Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM
    Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization of breast lesions: Visual and quantitative analyses.
    Kim IJ; Kim SJ; Kim YK
    Neoplasma; 2008; 55(6):526-31. PubMed ID: 18999882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
    Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R
    Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.